Jci_page_head_homepage_01 Jci_page_head_homepage_02
Adrian Erlebacher, Daniela Vencato, Kelly A. Price, Dorothy Zhang, Laurie H. Glimcher
Published in Volume 117, Issue 5
J Clin Invest. 2007; 117(5):1399–1411 doi:10.1172/JCI28214
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 4
Indirect presentation of fetal/placental OVA to maternal OT-I T cells.

(A) OT-I cells on a B6CBAF1 background are able to detect Kb/SIINFEKL complexes in (bm1 × CBA)F1 mice. Splenocytes from (bm1 × CBA)F1 or B6CBAF1 female virgins were analyzed 2 days after the injection of CFSE-labeled B6CBAF1 OT-I cells, with or without a concurrent injection of SIINFEKL-loaded B6CBAF1 splenocytes. Histograms were normalized to account for the loss of OT-I cells in (bm1 × CBA)F1 mice. (B) Lack of OT-I proliferation in (bm1 × CBA)F1 females mated to Act-mOVA males. Splenocytes from B6- or Act-mOVA–mated (bm1 × CBA)F1 females were analyzed 2 days after the injection of CFSE-labeled B6CBAF1 OT-I cells on or after E12.5. Data are representative of n = 10 Act-mOVA–mated (bm1 × CBA)F1 and n = 3 B6-mated mice in 3 independent experiments. Identical results were obtained with LN cells.